The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma
Open Access
- 31 August 2013
- journal article
- research article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 107 (8), 1141-1151
- https://doi.org/10.1016/j.rmed.2013.04.017
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of Omalizumab as Add-On Therapy on Asthma-Related Quality of Life in Severe Allergic Asthma: A Brazilian Study (QUALITX)Journal of Asthma, 2012
- Uncontrolled persistent allergic asthma in practice: eXpeRience registry baseline characteristicsCurrent Medical Research and Opinion, 2011
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City ChildrenThe New England Journal of Medicine, 2011
- Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthmaAllergy, 2011
- Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthmaCurrent Medical Research and Opinion, 2010
- Asthma control in adultsBMJ, 2006
- Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthmaClinical & Experimental Allergy, 2004
- Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- Nonadherence in Asthmatic Patients: Is there a Solution to the Problem ?Annals of Allergy, Asthma & Immunology, 1997
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994